short2312 schreef op 31 maart 2012 12:14:
1.De bondholders are repaid with shares. At what price they get those shares?
2.If the equity increases again? Is there already some insight?
3.It would be good for investors in Pharming, that they be kept better informed about the financial situtie,
and forecast of Sales (sales). I understand that this "sensitive" information,
but this should already be announced in the quarterly report. Why for example no monthly update?
4.If a reverse split considered? Example 100 old shares for 1 new one?
This may be more "big" investors / attract investors in the share.
5.Why is there never a rights issue made to reduce losses of existing shareholders?
6.Remains pharming new shares bijprinten until sales come in 2014? ("IF" there is approval)
7.How many personel has pharming?
8.Why your top employees earn much money in these difficult times?
9.Did you also read the message of ViroPharma (29/3), using bribes scatters to the HAE patient association (USA).
10.What happens if the application Pharming U.S. does not travel through the third quarter?
11.Have you ever heard of an anaphylactic shock?
In the Netherlands there is the fear (through Dr. Levi AMC) that 4% of patients at risk when using Ruconest HAE patients
and with great rapidity to the nearest hospital to be transported.
12.How come there Pharming virtually nothing about message?
13.Is this heavy whipped or there is a grain of truth?
14.When will the acquisition announced by Saturn.
15.Do you, like Mr. de Vries, the share e.0, 25 worth?
chiddix svp duidelijke vragen zoals bovenstaande stellen
alle vragenstellers kunnen corriceren als er iets fout staat
succes :-)
translate.google.com/#